Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.
Versteegen P, Barkoff AM, Valente Pinto M, van de Kasteele J, Knuutila A, Bibi S, de Rond L, Teräsjärvi J, Sanders K, de Zeeuw-Brouwer ML, Luoto R, Ten Hulscher H, Clutterbuck EA, Sanders EAM, Mertsola J, Berbers GAM, He Q, Kelly DF, Buisman AM; PERISCOPE Consortium. Versteegen P, et al. Among authors: valente pinto m. Front Immunol. 2022 May 23;13:864674. doi: 10.3389/fimmu.2022.864674. eCollection 2022. Front Immunol. 2022. PMID: 35677044 Free PMC article. Clinical Trial.
Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom.
Versteegen P, Valente Pinto M, Barkoff AM, van Gageldonk PGM, van de Kassteele J, van Houten MA, Sanders EAM, de Groot R, Diavatopoulos DA, Bibi S, Luoto R, He Q, Buisman AM, Kelly DF, Mertsola J, Berbers GAM. Versteegen P, et al. Among authors: valente pinto m. EBioMedicine. 2021 Mar;65:103247. doi: 10.1016/j.ebiom.2021.103247. Epub 2021 Feb 26. EBioMedicine. 2021. PMID: 33647770 Free PMC article. Clinical Trial.
Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants.
Valente Pinto M, O'Connor D, Galal U, Clutterbuck EA, Robinson H, Plested E, Bibi S, Camara Pellisso S, Hughes H, Kerridge S, Mujadidi YF, Findlow H, Borrow R, Snape MD, Pollard AJ. Valente Pinto M, et al. Open Forum Infect Dis. 2020 Apr 29;7(5):ofaa143. doi: 10.1093/ofid/ofaa143. eCollection 2020 May. Open Forum Infect Dis. 2020. PMID: 32494580 Free PMC article.
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.
Davis K, Valente Pinto M, Andrews NJ, Goldblatt D, Borrow R, Findlow H, Southern J, Partington J, Plested E, Patel S, Holland A, Matheson M, England A, Hallis B, Miller E, Snape MD. Davis K, et al. Among authors: valente pinto m. Lancet Infect Dis. 2021 May;21(5):688-696. doi: 10.1016/S1473-3099(20)30600-9. Epub 2021 Jan 8. Lancet Infect Dis. 2021. PMID: 33428870 Free article. Clinical Trial.
Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing.
Valente Pinto M, Davis K, Andrews N, Goldblatt D, Borrow R, Southern J, Nordgren IK, Vipond C, Plested E, Miller E, Snape MD. Valente Pinto M, et al. Vaccine. 2020 Nov 17;38(49):7834-7841. doi: 10.1016/j.vaccine.2020.10.023. Epub 2020 Oct 24. Vaccine. 2020. PMID: 33109390
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial.
Goldblatt D, Southern J, Andrews NJ, Burbidge P, Partington J, Roalfe L, Valente Pinto M, Thalasselis V, Plested E, Richardson H, Snape MD, Miller E. Goldblatt D, et al. Among authors: valente pinto m. Lancet Infect Dis. 2018 Feb;18(2):171-179. doi: 10.1016/S1473-3099(17)30654-0. Epub 2017 Nov 22. Lancet Infect Dis. 2018. PMID: 29174323 Free PMC article. Clinical Trial.